K-Chews 50This page contains information on K-Chews 50 for veterinary use.
The information provided typically includes the following:
- K-Chews 50 Indications
- Warnings and cautions for K-Chews 50
- Direction and dosage information for K-Chews 50
K-chews 50This treatment applies to the following species:
Vitamin K1 50 Mg
For Use In Dogs Only
Keep Out Of Reach Of Children
K-Chews 50 CautionFederal law restricts this drug to use by or on the order of a licensed veterinarian.
K-Chews 50 IndicationsK-Chews 50 (Vitamin K1 Chewable Tablets) is indicated in dogs to counter hypoprothrombinemia induced by ingestion of coumarin-based compounds, common ingredients of commercial rodenticides, and other drug induced hypoprothrombinemia where it is definitely shown that the result is due to interference with vitamin K metabolism, i.e. salicylates.
Dosage For DogsAcute hypoprothrombinemia (with hemorrhage) - Administer orally at the rate of 2.5-5.0 mg/kg body weight (1 chewable tablet per each 44 pounds of body weight for lower dosage or 1 chewable tablet per each 22 pounds for higher dosage) daily as conditions require up to three weeks. Frequency and amount of oral administration should be guided by regular determination of prothrombin time.
Regular determinations of prothrombin time response should be performed to guide in the initial and subsequent administration of K-Chews 50 (Vitamin K1 Chewable Tablets). The dosage should be adjusted accordingly. The smallest effective dose should be sought to minimize the risk of adverse reactions.
AdministrationEach K-Chews 50 (Vitamin K1 Chewable Tablets) may be given orally to dogs as a treat, or crumbled over their food. If crumbled over food, consumption should be monitored.
CompositionEach scored, round, chewable tablet contains 50 mg of phytonadione in a proprietary, highly palatable roast beef and liver flavor base.
K-Chews 50 Caution(s)Temporary resistance to prothrombin-depressing anticoagulants may result, especially when larger doses of phytonadione are used. It is recommended that K-Chews 50 (Vitamin K1 Chewable Tablets) be used in follow-up therapy only after administration of K-Ject (or other Vitamin K1 Injection) and hospitalization is no longer required. An immediate coagulant effect should not be expected after administration of phytonadione when administered orally.
Phytonadione will not counteract the anticoagulant action of heparin. Repeated large doses of Vitamin K1 are not warranted in hepatic disease if the response to the initial therapy is unsatisfactory. Failure to respond to Vitamin K1 may indicate that the condition being treated is inherently unresponsive to Vitamin K1.
Store at controlled room temperature; 15° C-30° C (59° F-86° F) and protect from light. Dispense in this container or another tight, light-resistant container.
Distributed Exclusively by: Butler Animal Health Supply, Dublin, OH 43017
Value Based, Solutions Driven
50 Chewable Tablets
A Henry Schein Company
400 METRO PLACE NORTH, DUBLIN, OH, 43017-7545
|Every effort has been made to ensure the accuracy of the K-Chews 50 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2013 North American Compendiums. Updated: 2013-05-17